The targeted localization of maximal concentrations of the therapeutic to the cellular/subcellular site of action in pathologically damaged tissues is one of the recurring obstacles in therapeutic drug delivery. Small molecule medications lack tissue and organ selectivity, have quick in vivo body clearance, and are frequently associated with a slew of adverse effects, particularly chemotherapeutic treatments, which are extremely toxic. Drug delivery systems (DDS) have been employed as one of the most promising solutions to solve this issue in recent decades. Cell-mediated DDS has emerged as a promising technique for addressing the aforementioned issues in recent years. Cell-mediated DDS has emerged as a new branch of therapy that allows for tailored distribution, increased circulation time, and decreased cellular and tissue toxicity. Intracellular delivery/therapy is a critical topic that will pique people's curiosity. Because the drug is not provided externally within the bloodstream, intracellular delivery allows for far more efficient drug delivery because the impact (on various organelles and locations) is intracellular. Targeted delivery with increased localized delivery and efficacy has a lot of potential.
Title : Liver biopsy handling of Metabolic-Associated Fatty Liver Disease (MAFLD): The children's hospital of eastern Ontario grossing protocol
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Haptoglobin-Related Protein Without Signal Peptide as biomarker of renal salt wasting (HPRWSP) in hyponatremia, hyponatremia-related diseases and as new syndrome in alzheimer’s disease
John K Maesaka, NYU Langone Hospital Long Island, United States
Title : Revolutionizing healthcare and pharma: Artificial intelligence-powered scientific communications and medical writing
Alessandro Gallo, Springer Healthcare, Italy
Title : Enabling knowledge-driven integration and interoperability in intelligent and ethical transformed health ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up via biodesign-driven biotech and upgraded biomarketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Integration of nanotechnology into complex treatment of multiple sclerosis
Andrey Belousov, Kharkiv National Medical University, Ukraine
Title : Preparation and characterization of fibers made from PCL/PVP-ChAgG, along with exploring their potential as wound dressings
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Photoremoval of ketoprofen, naproxen and phenazopyridine from pharmaceutical residues in a hospital wastewater treatment plant via Fe3O4-MnO2@rGO nanocomposite
Delia Teresa Sponza, Dokuz Eylul University, Turkey
Title : Combating aluminium chloride-induced alzheimer's in rats: Neuroprotective effects of Nelumbo nucifera and Bergenia ligulate
Nilay Solanki, Ramanbhai Patel College of Pharmacy, India
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets. Discovery of agonists and antagonists of OR51E1, an understudied G Protein-Coupled Receptor
Vladlen Slepak, University of Miami, United States